The report titled “United States In-Vitro Diagnostics Market Analysis 2024-2030: Industry Trends, Growth, Share, Outlook, and Opportunity Company Analysis” has been included in ResearchAndMarkets.com’s offerings.
The United States In-Vitro Diagnostics (IVD) Market is projected to reach approximately US$ 56.52 Billion by 2030, up from US$ 41.19 Billion in 2023, growing at a CAGR of 4.62% during 2024-2030.
Advancements in technology, improved accuracy, and faster results are driving the increased adoption of IVD. These tests, conducted on samples like blood or tissues outside the body, play a crucial role in disease prognosis, monitoring, and treatment. The rising demand for IVD solutions across various healthcare settings is primarily due to the significant benefits of personalized treatments and early disease detection, which lead to improved patient outcomes.
The market is witnessing significant growth with the development of automated IVD systems that offer enhanced efficiency, accuracy, and throughput. This signifies a commitment to enhancing patient care through innovative technology, positioning the United States as a leader in the in-vitro diagnostics market. Additionally, the increasing prevalence of infectious and chronic diseases is expected to drive the adoption of in vitro diagnostic testing methods. For instance, the estimated number of new cancer cases in 2023 was approximately 1.96 million in the U.S., with around 609,820 cancer-related deaths.
The aging population in the United States is a key factor contributing to market growth. As the elderly population requires regular health monitoring and disease management, there is a growing need for diagnostic tests related to age-related conditions such as cardiovascular disease, cancer, and diabetes. With over 54 million senior citizens aged 65 and above in the U.S. (16.5% of the population), and projected to exceed 85.7 million by 2050, there is a clear demand for advanced diagnostic technology to support early detection, optimized treatment, and improved quality of life for older adults, thus driving the in-vitro diagnostics market.
Technological advancements are driving growth in the United States IVD market, with innovations like next-generation sequencing, digital PCR, and advanced imaging techniques promising higher accuracy, sensitivity, and specificity in diagnostic testing. These advancements enable early disease detection, personalized treatment approaches, and more efficient laboratory workflows, ultimately leading to improved patient outcomes, reduced healthcare costs, and advancements in diagnostic capabilities.
PCR technology, known for its versatility, sensitivity, and wide applicability, is expected to witness significant growth in the U.S. IVD market due to its vital role in diagnosing infectious diseases, genetic disorders, and cancer. Instruments are also anticipated to be a leading product category, offering critical support in conducting diagnostic tests efficiently and accurately, thereby contributing to the overall growth and evolution of the IVD market. Additionally, hematology is poised to be a rapidly growing segment, driven by the increasing prevalence of blood disorders and technological advancements in hematology analyzers, enhancing diagnostic capabilities and driving adoption in medical laboratories and healthcare settings.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 135 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $41.19 Billion |
| Forecasted Market Value (USD) by 2030 | $56.52 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | United States |
Company Analysis:
1. Roche Diagnostics
2. Danaher Corporation
3. Thermofisher Scientific Inc.
4. Bio-Rad Laboratories, Inc.
5. Biomerieux
6. Abbott Laboratories
7. Sysmex Corporation
Test Types – Market breakup in 11 viewpoints:
1. ELISA & CLIA
2. PCR
3. Rapid Test
4. Fluorescence Immunoassays (FIA)
5. In Situ Hybridization
6. Transcription Mediated Amplification
7. Sequencing
8. Colorimetric Immunoassay
9. Radioimmunoassay (RIA)
10. Isothermal Nucleic Acid Amplification Technology
11. Others
Product – Market breakup in 3 viewpoints:
1. Reagents
2. Instruments
3. Services
Application – Market breakup in 7 viewpoints:
1. Immunochemistry
2. Clinical Chemistry
3. Hematology
4. Coagulation
5. Molecular Diagnostics
6. Microbiology
7. Others
